Cynata Therapeutics Limited (ASX: CYP) announced it has completed patient enrollment in its Phase 2 clinical trial of CYP-001 for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE